Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022
Geneva, Switzerland, November 3, 2022 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug…